The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kunelskaya N.L.

L. I. Sverzhevsky Research Clinical Institute of Otorhinolaryngology;
Pirogov Russian National Research Medical University

Zaoeva Z.O.

Sverzhevky Research Clinical Institute of Otorhinolaryngology

Vasilchenko N.O.

Sverzhevsky Research Clinical Institute of Otorhinolaryngology

Chugunova M.A.

Sverzhevky Research Clinical Institute of Otorhinolaryngology

Revazishvili S.D.

L.I. Sverzhevsky Research Clinical Institute of Otorhinolaryngology

Biochemical features of migraine pathogenesis

Authors:

Kunelskaya N.L., Zaoeva Z.O., Vasilchenko N.O., Chugunova M.A., Revazishvili S.D.

More about the authors

Read: 1441 times


To cite this article:

Kunelskaya NL, Zaoeva ZO, Vasilchenko NO, Chugunova MA, Revazishvili SD. Biochemical features of migraine pathogenesis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(4):21‑26. (In Russ.)
https://doi.org/10.17116/jnevro202512504121

Recommended articles:
Oxidative stress in the pathogenesis of chro­nic headache. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):35-40
Neurochemical mechanisms of tremor in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):64-72
The rela­tionship of diet and nutrition with the frequency of migraine atta­cks. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):30-35
The main mechanisms of deve­lopment of cognitive impairment. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):13-18
Nutrition, inte­stinal microbiota, and thyroid autoimmune pathology. Russian Journal of Preventive Medi­cine. 2025;(1):102-108
Meniere’s disease and vestibular migraine: differential diagnostics and treatment. Russian Bulletin of Otorhinolaryngology. 2025;(1):57-63

References:

  1. Koreshkina MI. Modern methods of neurovisualization and preventive treatment of migraine. S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(9):25-31. (In Russ.).
  2. Sadokha KA. Migraine: classification, diagnostics, treatment. Meditsinskie novosti. 2015;7:26-30. Accessed November 10,2024. (In Russ.). https://cyberleninka.ru/article/n/migren-klassifikatsiya-diagnostika-lechenie-1
  3. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211.  https://doi.org/10.1177/0333102417738202
  4. Aguilar-Shea AL, Membrilla Md JA, Diaz-de-Teran J. Migraine review for general practice. Aten Primaria. 2022;54(2):102208. https://doi.org/10.1016/j.aprim.2021.102208
  5. Tabeeva GR, Katsarava Z, Dmitriev GV, et al. Migraine in the real-life clinical practice: results of the observational study of diagnosis and treatment patterns in the urban population of the Russian Federation. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(12):40-50. (In Russ.). https://doi.org/10.17116/jnevro202112112140
  6. Stewart WF, Wood C, Reed ML, et al; AMPP Advisory Group. Cumulative lifetime migraine incidence in women and men. Cephalalgia. 2008;28(11):1170-1178. https://doi.org/10.1111/j.1468-2982.2008.01666.x
  7. Tabeeva GR, Katsarava Z. Current concept of the pathophysiology of migraine and new targets for its therapy. Nevrologiya, neiropsikhiatriya, psikhosomatika=Neurology, Neuropsychiatry, Psychosomatics. 2020;12(4):143-152. (In Russ.). https://doi.org/10.14412/2074-2711-2020-4-143-152
  8. Khan J, Asoom LIA, Sunni AA, et al. Genetics, pathophysiology, diagnosis, treatment, management, and prevention of migraine. Biomed Pharmacother. 2021;139:111557. https://doi.org/10.1016/j.biopha.2021.111557
  9. Ferroni P, Barbanti P. Biomarkers in Migraine Headache: Prognostic and Therapeutic Implications. Curr Med Chem. 2019;26(34):6188-6190. https://doi.org/10.2174/092986732634191112142448
  10. Ashina M, Terwindt GM, Al-Karagholi MA, et al. Migraine: disease characterisation, biomarkers, and precision medicine. Lancet. 2021;397(10283):1496-1504. https://doi.org/10.1016/S0140-6736(20)32162-0
  11. Tabeeva GR, Kosivtsova OV. Modern strategies for the treatment of migraine attacks and the possibility of a differentiated approach. Meditsinskiy sovet=Medical Council. 2023;(21):54-62. (In Russ.). https://doi.org/10.21518/ms2023-425
  12. AkdaĞ T, Uca AU. Cystatin C as a potential biomarker to evaluate migraine. Arq Neuropsiquiatr. 2020;78(6):337-341.  https://doi.org/10.1590/0004-282X20200005
  13. Brunklaus A, Brünger T, Feng T, et al. The gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications. Brain. 2022;145(11):3816-3831. https://doi.org/10.1093/brain/awac210
  14. de Boer I, Hansen JM, Terwindt GM. Hemiplegic migraine. Handb Clin Neurol. 2024;199:353-365.  https://doi.org/10.1016/B978-0-12-823357-3.00015-X
  15. Lempert T, von Brevern M. Vestibular Migraine. Neurol Clin. 2019;37(4):695-706.  https://doi.org/10.1016/j.ncl.2019.06.003
  16. Oh EH, Shin JH, Cho JW, et al. TRPM7 as a Candidate Gene for Vestibular Migraine. Front Neurol. 2020;11:595042. https://doi.org/10.3389/fneur.2020.595042
  17. Tabeeva GR, Yahno NN. Migraine. M.: GEOTAR-Media. 2011;620. (In Russ.).
  18. Gafurov BG, Husainova LT, Pulatova ShS. Some clinical and physiological features of male and female migraine. S.S. Korsakov Journal of Neurology and Psychiatry. 2001;101(12):57-58. (In Russ.).
  19. Karpova MI, Zariada AA, Dolgushina VF, et al. Migraine in women: clinical and therapeutical aspects. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;3:98-107. (In Russ.). https://doi.org/10.17116/jnevro201911903198
  20. Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology. 1999;53(3):537-542.  https://doi.org/10.1212/wnl.53.3.537
  21. Borsook D, Erpelding N, Lebel A, et al. Sex and the migraine brain. Neurobiol Dis. 2014;68:200-214.  https://doi.org/10.1016/j.nbd.2014.03.008
  22. Pavlovic JM, Akcali D, Bolay H, et al. Sex-related influences in migraine. J Neurosci Res. 2017;95(1-2):587-593.  https://doi.org/10.1002/jnr.23903
  23. Aegidius KL, Zwart JA, Hagen K, et al. Increased headache prevalence in female adolescents and adult women with early menarche. The Head-HUNT Studies. Eur J Neurol. 2011;18(2):321-328.  https://doi.org/10.1111/j.1468-1331.2010.03143.x
  24. Humphreys K. Avoiding globalisation of the prescription opioid epidemic. Lancet. 2017;390(10093):437-439.  https://doi.org/10.1016/S0140-6736(17)31918-9
  25. Quinlan J, Rann S, Bastable R, Levy N. Perioperative opioid use and misuse. Clin Med (Lond). 2019;19(6):441-445.  https://doi.org/10.7861/clinmed.2019.0227
  26. Kesserwani H. Migraine Triggers: An Overview of the Pharmacology, Biochemistry, Atmospherics, and Their Effects on Neural Networks. Cureus. 2021;13(4):e14243. https://doi.org/10.7759/cureus.14243
  27. MacGregor EA, Hackshaw A. Prevalence of migraine on each day of the natural menstrual cycle. Neurology. 2004;63(2):351-353.  https://doi.org/10.1212/01.wnl.0000133134.68143.2e
  28. Pavlović JM, Allshouse AA, Santoro NF, et al. Sex hormones in women with and without migraine: Evidence of migraine-specific hormone profiles. Neurology. 2016;87(1):49-56.  https://doi.org/10.1212/WNL.0000000000002798
  29. Glare P, Aubrey KR, Myles PS. Transition from acute to chronic pain after surgery. Lancet. 2019;393(10180):1537-1546. https://doi.org/10.1016/S0140-6736(19)30352-6
  30. Soave PM, Conti G, Costa R, et al. Magnesium and anaesthesia. Curr Drug Targets. 2009;10(8):734-743.  https://doi.org/10.2174/138945009788982487
  31. Woolf CJ. Evidence for a central component of post-injury pain hypersensitivity. Nature. 1983;306(5944):686-688.  https://doi.org/10.1038/306686a0
  32. Abdulatif M, Ahmed A, Mukhtar A, et al. The effect of magnesium sulphate infusion on the incidence and severity of emergence agitation in children undergoing adenotonsillectomy using sevoflurane anaesthesia. Anaesthesia. 2013;68(10):1045-1052. https://doi.org/10.1111/anae.12380
  33. Czarnetzki C, Lysakowski C, Elia N, et al. Time course of rocuronium-induced neuromuscular block after pre-treatment with magnesium sulphate: a randomised study. Acta Anaesthesiol Scand. 2010;54(3):299-306.  https://doi.org/10.1111/j.1399-6576.2009.02160.x
  34. Hwang JY, Na HS, Jeon YT, et al. IV. infusion of magnesium sulphate during spinal anaesthesia improves postoperative analgesia. Br J Anaesth. 2010;104(1):89-93.  https://doi.org/10.1093/bja/aep334
  35. El Mourad MB, Arafa SK. Effect of intravenous versus intraperitoneal magnesium sulfate on hemodynamic parameters and postoperative analgesia during laparoscopic sleeve gastrectomy-A prospective randomized study. J Anaesthesiol Clin Pharmacol. 2019;35(2):242-247.  https://doi.org/10.4103/joacp.JOACP_208_18
  36. Jabbour H, Jabbour K, Abi Lutfallah A, et al. Magnesium and Ketamine Reduce Early Morphine Consumption After Open Bariatric Surgery: a Prospective Randomized Double-Blind Study. Obes Surg. 2020;30(4):1452-1458. https://doi.org/10.1007/s11695-019-04317-1
  37. Tabeeva GR, Gromova SA. Estrogens and migraine. Nevrologicheskiy jurnal. 2009;5:45-52. (In Russ.).
  38. Herzog AG. Neuroactive properties of reproductive steroids. Headache. 2007;47 Suppl 2:S68-S78.  https://doi.org/10.1111/j.1526-4610.2007.00817.x
  39. Altıparmak B, Çelebi N, Canbay Ö, et al. Effect of magnesium sulfate on anesthesia depth, awareness incidence, and postoperative pain scores in obstetric patients. A double-blind randomized controlled trial. Saudi Med J. 2018;39(6):579-585.  https://doi.org/10.15537/smj.2018.6.22376
  40. Kizilcik N, Koner O. Magnesium Sulfate Reduced Opioid Consumption in Obese Patients Undergoing Sleeve Gastrectomy: a Prospective, Randomized Clinical Trial. Obes Surg. 2018;28(9):2783-2788. https://doi.org/10.1007/s11695-018-3243-7
  41. Patil M, Belugin S, Mecklenburg J, et al. Prolactin Regulates Pain Responses via a Female-Selective Nociceptor-Specific Mechanism. iScience. 2019;20:449-465.  https://doi.org/10.1016/j.isci.2019.09.039
  42. Szewczyk AK, Ulutas S, Aktürk T, et al. Prolactin and oxytocin: potential targets for migraine treatment. J Headache Pain. 2023;24(1):31.  https://doi.org/10.1186/s10194-023-01557-6
  43. Cavestro C, Rosatello A, Marino MP, et al. High prolactin levels as a worsening factor for migraine. J Headache Pain. 2006;7(2):83-89.  https://doi.org/10.1007/s10194-006-0272-8
  44. Schulte LH, May A. The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks. Brain. 2016;139(Pt 7):1987-1993. https://doi.org/10.1093/brain/aww097
  45. Strother LC, Srikiatkhachorn A, Supronsinchai W. Targeted Orexin and Hypothalamic Neuropeptides for Migraine. Neurotherapeutics. 2018;15(2):377-390.  https://doi.org/10.1007/s13311-017-0602-3
  46. Goadsby PJ, Goldberg J, Silberstein SD. Migraine in pregnancy. BMJ. 2008;336(7659):1502-1504. https://doi.org/10.1136/bmj.39559.675891.AD
  47. Ekusheva EV, Damulin IV. Current approaches to treatment of migraine during pregnancy. S.S. Korsakov Journal of Neurology and Psychiatry. 2015;11:124-132. (In Russ.). https://doi.org/10.17116/jnevro2015115111124-132
  48. van Oosterhout WPJ, Schoonman GG, van Zwet EW, et al. Female sex hormones in men with migraine. Neurology. 2018;91(4):e374-e381. https://doi.org/10.1212/WNL.0000000000005855
  49. Shields LBE, Seifert T, Shelton BJ, et al. Testosterone levels in men with chronic migraine. Neurol Int. 2019;11(2):8079. https://doi.org/10.4081/ni.2019.8079
  50. Tang B, Yu X, Jiang W, et al. Clinical significance of serum sex hormones in postmenopausal women with vestibular migraine: potential role of estradiol. J Int Med Res. 2021;49(5):3000605211016379. https://doi.org/10.1177/03000605211016379
  51. Shestakov VV, Starikova NL. Clinical features of migraine and parameters of trigeminal somatosensory evoked potentials in patients with different levels of thyroid-stimulating hormone. S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(12):77-81. Accessed November 10,2024. (In Russ.). https://www.mediasphera.ru/issues/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova/2010/12/downloads/ru/031997-729820101215
  52. Bhattacharjee M, Karim MR, Rahman MA, et al. Association of Low Thyroid Hormone with Migraine Headache. Mymensingh Med J. 2021;30(1):43-47. Accessed November 10,2024. https://www.researchgate.net/publication/348734010_Association_of_Low_Thyroid_Hormone_with_Migraine_Headache
  53. Rubino E, Rainero I, Garino F, et al. Subclinical hypothyroidism is associated with migraine: A case-control study. Cephalalgia. 2019;39(1):15-20.  https://doi.org/10.1177/0333102418769917
  54. Tasnim S, Nyholt DR. Migraine and thyroid dysfunction: Co-occurrence, shared genes and biological mechanisms. Eur J Neurol. 2023;30(6):1815-1827. https://doi.org/10.1111/ene.15753
  55. Togha M, Razeghi Jahromi S, Ghorbani Z, et al. Serum Vitamin D Status in a Group of Migraine Patients Compared With Healthy Controls: A Case-Control Study. Headache. 2018;58(10):1530-1540. https://doi.org/10.1111/head.13423
  56. Liampas I, Siokas V, Brotis A, et al. Vitamin D serum levels in patients with migraine: A meta-analysis. Rev Neurol (Paris). 2020;176(7-8):560-570.  https://doi.org/10.1016/j.neurol.2019.12.008
  57. Urits I, Yilmaz M, Bahrun E, et al. Utilization of B12 for the treatment of chronic migraine. Best Pract Res Clin Anaesthesiol. 2020;34(3):479-491.  https://doi.org/10.1016/j.bpa.2020.07.009
  58. Togha M, Razeghi Jahromi S, Ghorbani Z, et al. Serum Vitamin B12 and Methylmalonic Acid Status in Migraineurs: A Case-Control Study. Headache. 2019;59(9):1492-1503. https://doi.org/10.1111/head.13618
  59. Gallai V, Sarchielli P, Morucci P, et al. Red blood cell magnesium levels in migraine patients. Cephalalgia. 1993;13(2):94-73.  https://doi.org/10.1046/j.1468-2982.1993.1302094.x
  60. Thomas J, Millot JM, Sebille S, et al. Free and total magnesium in lymphocytes of migraine patients — effect of magnesium-rich mineral water intake. Clin Chim Acta. 2000;295(1-2):63-75.  https://doi.org/10.1016/s0009-8981(00)00186-8
  61. Dolati S, Rikhtegar R, Mehdizadeh A, et al. The Role of Magnesium in Pathophysiology and Migraine Treatment. Biol Trace Elem Res. 2020;196(2):375-383.  https://doi.org/10.1007/s12011-019-01931-z
  62. Sun-Edelstein C, Mauskop A. Role of magnesium in the pathogenesis and treatment of migraine. Expert Rev Neurother. 2009;9(3):369-379.  https://doi.org/10.1586/14737175.9.3.369
  63. Shin HJ, Na HS, Do SH. Magnesium and Pain. Nutrients. 2020;12(8):2184. Published 2020 Jul 23.  https://doi.org/10.3390/nu12082184
  64. Yin P, Anttila V, Siewert KM, et al. Serum calcium and risk of migraine: a Mendelian randomization study. Hum Mol Genet. 2017;26(4):820-828.  https://doi.org/10.1093/hmg/ddw416
  65. Rakhmanina OA, Levitina EV, Juravleva TD. Calcium homeostasis and nitric oxide processes in children with migraine. Klinicheskaya Laboratornaya Diagnostika (Russian Clinical Laboratory Diagnostics). 2008;6:39-40. (In Russ.).
  66. Tabeeva GR, Sergeev AV, Gromova SA. New aspects of neurobiology of migraine: the role of hypothalamic-pineal system. S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(8):79-85. Accessed November 10,2024. (In Russ.). https://www.mediasphera.ru/issues/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova/2011/8/downloads/ru/031997-72982011818
  67. Srinivasan V, Lauterbach EC, Ho KY, et al. Melatonin in antinociception: its therapeutic applications. Curr Neuropharmacol. 2012;10(2):167-178.  https://doi.org/10.2174/157015912800604489
  68. Liampas I, Siokas V, Brotis A, et al. Endogenous Melatonin Levels and Therapeutic Use of Exogenous Melatonin in Migraine: Systematic Review and Meta-Analysis. Headache. 2020;60(7):1273-1299. https://doi.org/10.1111/head.13828
  69. Karsan N, Goadsby PJ. Biological insights from the premonitory symptoms of migraine. Nat Rev Neurol. 2018;14(12):699-710.  https://doi.org/10.1038/s41582-018-0098-4
  70. Evtushenko AS, Lekomtseva EV, Tovajnyanskaya EL, et al. Content of tryptophan and serotonin in blood of young people with initial forms of migraine. Meditsina segodnya i zavtra. 1999;3/4:69-70. (In Russ.).
  71. Charleston L 4th, Khalil S, Young WB. Carnitine Responsive Migraine Headache Syndrome: Case Report and Review of the Literature. Curr Pain Headache Rep. 2021;25(4):26.  https://doi.org/10.1007/s11916-021-00936-5
  72. Fila M, Chojnacki J, Pawlowska E, et al. Kynurenine Pathway of Tryptophan Metabolism in Migraine and Functional Gastrointestinal Disorders. Int J Mol Sci. 2021;22(18):10134. https://doi.org/10.3390/ijms221810134
  73. Majláth Z, Veres G, Zádori D, et al. EHMTI-0189. Tryptophan-kynurenine metabolism in migraine patients. J Headache Pain. 2014;15(Suppl 1):E17.  https://doi.org/10.1186/1129-2377-15-S1-E17

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.